Catalyst Wire Dossier Catalyst Wire Dossier

Betamethasone Dipropionate Nasal Cream

betamethasone dipropionate · Oticara Australia Pty Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Betamethasone Dipropionate Nasal Cream, covering 2024-05-02 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS) [Phase 2]

See pricing